India  

Equity indices end flat, Wipro gains 9%

Video Credit: ANI - Duration: 01:11s - Published
Equity indices end flat, Wipro gains 9%

Equity indices end flat, Wipro gains 9%

Equity benchmark indices ended flat after a volatile session on Friday with investors staying on the sidelines as COVID-19 situation gets grimmer by the day.

The BSE SandP Sensex closed 28 points or 0.06 per cent higher at 48,832 while the Nifty 50 ticked up by 36 points or 0.25 per cent to 14,618.

Sectoral indices at the National Stock Exchange were mixed Nifty pharma surging by 1.9 per cent, auto and IT by 1.1 per cent each, and metal by 0.8 per cent.

Among stocks, IT software major Wipro moved up by 9 per cent to Rs 469.45 per share after reporting 28 per cent y-o-y jump in net profit at Rs 2,972 crore for the quarter ended March.


You Might Like


💡 newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

Bust Premiership trio owe £30m in unpaid Covid loans

London Irish, Wasps and Worcester went out of business needing to repay more than £30m of Covid relief loans, a National Audit Office report says.
BBC Sport

Related videos from verified sources

Equity indices close flat, JSW Steel up 9 pc [Video]

Equity indices close flat, JSW Steel up 9 pc

Equity benchmark indices trimmed early gains to close flat on April 29 after traders booked profit in auto and financial scrips amid economic uncertainty. The BSE SandP Sensex closed 32 points or 0.06..

Credit: ANI     Duration: 01:11Published
Equity gauges on upswing, Wipro top gainer [Video]

Equity gauges on upswing, Wipro top gainer

Equity benchmark indices traded in the positive terrain during early hours on Friday led by IT and auto stocks amid mixed Asian cues. At 10:15 am, the BSE S-P Sensex was up by 163 points or 0.33 per..

Credit: ANI     Duration: 01:11Published
Equity indices trade flat, Infosys drops 3.8 pc [Video]

Equity indices trade flat, Infosys drops 3.8 pc

Equity benchmark indices traded flat during early hours on April 15 amid an interplay of resurgence in COVID-19 cases and the pace of vaccination. Investors tracked updates on the vaccines approval and..

Credit: ANI     Duration: 01:17Published